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1. Introduction
1.1. Background
  Resource poor countries like those in Africa face a 
triple burden of disease. Human immunodeficiency virus, 
tuberculosis and malaria are changing the population 
dynamics of many resource poor countries by creating a 
larger young population and a significantly smaller middle 
to old age population. There are currently almost 5.6 million 
infected with HIV in South Africa, which is approximately 
11% of the South African population[1]. It is also estimated 
that there are almost 500 000 patients who exhibit AIDS 
defining conditions[2].
  Although there is currently no cure or vaccine for HIV 
infection, it can be managed by highly active antiretroviral 
therapy. The management of HIV is however complicated 
due to antiretroviral drug resistance. For the purpose of 
this paper, drug resistance may be defined as the inability 
of the antiretroviral (ARV) drugs to adequately suppress 
viral load. It was reported in 2009, that 37% of patients that 
required ARV treatment actually received ARV drugs[3]. 
The factors that facilitate antiretroviral drug resistance 
are high replication rates of the virus, selective pressure 
caused by the ARV drugs and initial infection by resistant 
strains of HIV. Thus it is inevitable that drug resistance will 
become concern in treatment of HIV/AIDS infected patients. 
Without effective ARV treatment patients are susceptible to 
opportunistic infections which may be fatal e.g. pneumonia 
and tuberculosis. AIDS related conditions, including ARV 
drug resistance causes 43.6% of deaths in the HIV positive 
population in South Africa[4].
  It thus follows that drug resistance testing may become 
routine in the treatment of HIV infected patients. Currently, 
phenotypic laboratory tests are used to determine if a 
patient is resistant to ARVs. These methods are however 
expensive, time consuming and prone to error. Electronic 
computerized algorithms[5-8] may also be used to determine 
ARV drug resistance, and have many advantages over 
phenotype testing. Computer based genotype interpretation 
algorithms usually determine mutations in the patient’s pol 
gene region, and uses this information to determine the ARV 
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drugs to which patients are resistant to. These computer 
based tests are faster and cheaper than phenotypic tests.
  Computer based algorithms are usually based on an 
experts’ understanding of the domain, available datasets 
that are used for machine learning and understanding of 
published literature. This has led to the creation of many 
different interpretation algorithms, which produce different 
resistance measures even if applied to the same resistance 
profile. 
  The aim of this study is to combine the interpretation of 
three gold standard interpretation algorithms using weighted 
heuristics in order to produce a single resistance profile.
1.2. Interpretation algorithms
  One type of interpretation algorithms is based on domain 
knowledge. These interpretation algorithms are logic or 
decision tree based expert systems that are made up of rules 
describing interactions between certain mutations and/or 
combination of mutations with resistance. This means that 
all computational decisions concerning resistance are based 
on known mutation-resistance rules found in published 
scientific literature.  
  REGA, Agence Nationale de Recherches sur le SIDA 
(ANRS) and HIV-db are widely used as the goal standards 
in interpretation algorithms. REGA was developed by the 
laboratory for clinical and evolutionary virology, Rega 
institute for medical research, Katholieke Universiteit 
Leuven. It classifies ARV resistance according to three 
levels, susceptible, intermediate and resistant. Susceptible 
indicates that for a given resistance profile, a particular 
ARV drug will be effective in managing the HIV infection. 
Intermediate indicates that the ARV drug is partially 
effective, and if the ARV is not effective the resistance 
profile is classified as resistant. REGA also incorporates the 
idea of a genotypic susceptibly score that is assigned to each 
drug for each of the three levels. Resistance to the therapy 
is confirmed when the sum of the individual genotypic 
susceptibility scores are lower than a pre-determined cutoff. 
The HIV-db program was developed by the Division for 
Infectious Diseases, Stanford University Medical Center, 
Stanford University. The expert system itself generates 
a resistance profile using Boolean based rules and also 
includes penalties. HIV-db classifies HIV resistance 
according to five levels: susceptible, potential low-level 
resistance, low-level resistance, intermediate resistance, 
and high-level resistance. The French National Agency for 
AIDS Research AC11 Resistance group developed the ANRS 
algorithm based on statistically determining the relationship 
between genome mutations and virological outcomes of 
patients failing ARV therapy. The ANRS classification of 
resistance is similar to REGA.
  These interpretation algorithms were however developed 
using different datasets, subtypes, analyzed on drug-naive 
and -experienced patients etc. These differences have led 
to the creation of many different interpretation algorithms. 
Initially, studies suggested that the interpretation algorithms 
produce different resistance measures even if applied to 
the same resistance profile. Recent studies with updated 
interpretation rules still suggested some discordance 
between interpretation algorithms. 
  Four interpretation algorithms (ANRS-3-02, TRUGENE 
VGI-6, Rega 5.5 and HIVdb-8-02) were studied[9] and 
it was concluded that there was a discrepancy in the 
interpretations of 33% of all the data  tested.  The most 
discordant were NRTI’s. De Luca et al[10] concluded that 
discrepancies in the interpretation algorithms may influence 
the use of resistance testing over virological outcomes. De 
Luca et al[11] later studied the application of 13 interpretation 
algorithms on drug naive patients and concluded that there 
were discordances. Wang et al[12] also determined that there 
was a high level of discordance between the interpretation of 
NRTI resistance, and goes on to suggest that there should be 
“standardization of unique interpretative rules”. Vergne et 
al[13] also confirmed some discrepancies and attributed them 
to the application of the interpretation algorithms to drug 
-naive or -experienced patients. Snoek et al[14] confirmed 
that there were low discordances between the algorithms 
tested and suggested it may be due to subtypes. Vercauteren 
et al[15] felt that the newer versions of interpretation 
algorithms were converging but there are some discrepancies 
in their interpretation. Poonpiriya et al[16] also found that 
some discrepancies in the seven interpretation algorithms 
they studied. Yebra et al[17] concluded that there were some 
discordance in interpretation of subtype B sequences, but 
more variation in non-B subtype interpretations.
1.3. Weighted voting techniques to combine classifiers
  The combination of classifiers has been shown in many 
studies to produce higher accuracies than the base 
classifiers alone[18-20]. One method of combining classifiers 
is to use weighed voting techniques[21,22]. Three examples 
of such ensemble techniques are simple additive voting, 
accuracy based voting and Bayesian based weighted voting 
algorithms[23].  
  In the simple additive voting technique, each individual 
classifier has an equal weighting contribution to the 
single combined output. The single resistance measure is 
obtained by determining the resistance measure that is most 
suggested by the gold standard interpretation algorithms. 
If the three gold standard interpretation algorithms each 
suggest different resistance measures, the middle measure 
is reported. Accuracy based voting technique uses the 
normalized accuracy of each gold standard interpretation 
algorithm as the weight additively assigned to the resistance 
profile. The resistance profile with the highest summed 
weight is reported as the single resistant output. 
  In order to apply the Bayesian based voting, assume C is a 
confusion matrix for each expert classifier (e) with M possible 
classes, such that C is the number of class i patterns that 
classifier k assigns to class j. Thus the probability that a 
pattern x actually belongs to class i, given that k experts 
assign in to class j, can be calculated from Equation 1.  Thus 
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for any pattern x such that the K experts classify it as e(k) 
= jk for 1< k < K, the belief, B, that the pattern x belongs to 
class i may be obtained from Equation 2. Applying Bayes 
formula, B(i) may be approximated by Equation 3. Thus any 
pattern x can be assigned to class i if B(i) > B(j) for all 1 < j < 
M and i ≠ j.
2. Materials and methods
  The methodology employed in this study was broken 
down into four parts, namely, data pre-processing, 
data processing, classification algorithm combination 
and statistical analysis of the combined interpretation 
algorithms. 
2.1. Data pre-processing
  Genotype-Phenotype datasets that consisted of 2 928 
protease gene and 1 981 reverse transcriptase gene 
sequences were obtained from the Stanford HIV drug 
resistance database (http://hivdb.stanford.edu/). This 
database contains publicaly available de-identified HIV 
drug resistance data. The dataset consisted of a sequence 
identifier, subtype of the sequence, phenotyping method, 
isolate identifier, fold resistance of drug compared to the 
wild type, amino acids at various positions, and mutation 
lists.
  The amino acid for each protease and reverse transcriptase 
sequence in the dataset was then processed into its 
respective three base nucleotide sequence. This was 
accomplished by feeding individual PR and RT sequences 
into a Java application that replaced each amino acid with 
the triplet nucleotide as shown in Table 1.   
Table 1. 
Triplet coding for each amino acid in the PR and RT sequences.
Amino acid Triplet codon Amino acid Triplet codon
Ala/A GCU Leu/L UUA
Arg/R CGU Lys/K AAA
Asn/N AAU Met/M AUG
Asp/D GAU Phe/F UUU
Val/V GUU Tyr/Y UAU
Ile/I AUU His/H CAU
Thr/T ACU Gly/G GGU
Glu/E GAA Gln/Q CAA
Cys/C UGU Pro/P CCU
Ser/S UCU Trp/W UGG
2.2. Data processing
  The nucleotide list was fed into to the online HIValg 
V6.0.11 program hosted by Stanford university (http://sierra2.
stanford.edu/sierra/servlet/JSierra?action=hivalgs). This web 
application takes as input the nucleotide list, converts this 
to an amino acid list, determines mutations that occur in the 
genome, and gives resistance profiles of that sequence by 
applying the REGA, HIVdb and ANRS algorithms to it. 
  The predicted output resistance profile for each sequence 
was linked with its original amino acid sequence and its 
associated phenotype IC50 score.  With respect to this study, 
the IC50 scores were treated as a true measurement of drug 
resistance. Based on the ranges of the IC50 score, an actually 
resistance measurement was determined.  
2.3. Combining the classifiers
  The outputs of HIVdb, Rega, ANRS were combined to obtain 
a single resistance profile using the equally weighted voting 
algorithm, accuracy based weighing voting algorithm and the 
Bayesian based weighted voting algorithm techniques. Excel 
was used to create the mathematical model that performed 
the combination.
2.4. Statistical analysis
  Standard deviation, z-score and p-score were calculated 
in order to perform a proportion test. This was calculated 
to determine if the accuracies obtained where statistically 
different from chance. The null hypothesis proposed was that 
the average accuracy observed resulted purely from chance 
i.e. Proportion(P)=0.5. The standard deviation was calculated 
as shown in Equation 4 and the Z-score as calculated from 
Equation 5. P-score was determined by solving Equation 
6. Similarly the proportional Z test was used to determine 
if the difference between the algorithms were statistically 
significant. 
 
  Another statistical method employed to determine if 
significant differences were produced by the different 
combination models was described by Salzberg[23]. It was 
reported that a P-score for comparing classifiers may be 
computed using the binomial distribution, which gives the 
probability of s successes in n trials as shown in Equation 7.
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  Thus, if we expect no difference between the algorithms, 
then p=q=0.5 and the p-score may be calculated as shown 
in Equation 8.
  Further analysis was performed to determine the 
distribution of the discrepancies were between the resistance 
measures in the misclassified data elements. Discrepancies 
were divided into three groups: G1, G2 and G3. G1 
represented no discrepancies between the Bayesian based 
voting algorithm and each of the three gold interpretation 
algorithms. G2 represent a single resistance measure 
difference between the Bayesian based voting algorithm and 
each of the three gold standard interpretation algorithms, 
i.e. intermediate classified as susceptible or resistant or vice 
versa. G3 represented a two resistance measure difference 
between the Bayesian based voting algorithm and each of 
the three gold interpretation algorithms, i.e. susceptible 
classified as resistant and vice versa.
3. Results
  Accuracy was calculated in order to determine the 
effectiveness and to compare the gold standard interpretation 
algorithms and the weighted voting algorithms. Accuracy is 
defined as the percentage of resistance profiles that have 
resistance measures as identified by the IC50 score. The 
accuracy obtained by each gold standard interpretation 
algorithm and weighted voting algorithm is shown in Table 
2. 
Table 2. 
The accuracy of the HIV-db, REGA, ANRS, equal weighting, accuracy 
weighting and bayesian weighting algorithms in predicting phenotype.
Drug ANRS HIVdb REGA Equal Accuracy Bayesian
Atv * * 69.8 69.8 69.8 69.8
Idv 51.6 51.3 51.9 52.8 52.8 69.8
Lpv 68.7 72.5 77.1 75.7 75.7 80
Nfv 57.4 55.5 54.2 55.9 57.9 65.4
Sqv 61.7 53 59.6 61.9 62.0 66.7
Tpv 64.6 61.7 57.8 66.7 62.4 75.1
3tc 67.9 68.8 69.0 68.9 68.8 75.3
Abc 50.1 48.7 50.6 48.0 48.0 55.6
Azt * 54.9 55.1 54.3 53.6 59.4
D4t 44.5 49.3 48.9 47.9 47.9 58.2
DDI 50.2 48.2 48.0 50.1 50.5 55.2
DLV * 64.8 67.4 63.8 62.4 72.4
EFV 65.9 64.6 65.9 62.9 62.9 70.0
NVP 73.6 74.6 75.7 77.6 78.0 81.0
TDF 48.1 45.5 46.5 47.9 47.8 79.0
*  indicates that the gold standard did not produce any results.
  The Salzberg method as described in Equations 8 was 
performed in order to compare the three weighted voting 
algorithms with each another to determine if there are any 
statistical differences between them. Table 3 describes the 
P-value obtained from the Salzberg when comparing the 
weighing algorithms. The comparison was also confirmed 
using the proportional Z-test. Table 4 shows the Z-score of 
the comparison of equal, accuracy, and Bayesian weighting 
algorithms.
Table 3. 
P-value of the comparison of the weighing algorithms using 
Salzberg’s method[23].
Drug
Equal weighting Accuracy weighing
Bayesian weightingAccuracy weighting Bayesian weighting
atv 0.9 0.9 1.0
idv 0.9 < 0.01 < 0.01
lpv <0.01 < 0.01 0.9
nfv 0.07 < 0.01 < 0.01
sqv 0.03 < 0.01 < 0.01
tpv 0.01 < 0.01 <0.01
3tc 0.9 < 0.01 0.9
abc 0.9 < 0.01 < 0.01
azt 0.9 < 0.01 < 0.01
d4t 0.9 < 0.01 < 0.01
ddi 0.9 < 0.01 < 0.01
dlv 0.9 < 0.01 < 0.01
efv 0.9   0.01   0.03
nvp 0.9 0.8 0.9
tdf 0.9 0.9 0.9
 
Table 4. 
Z-score of the comparison of equal, accuracy, Bayesian weighting 
algorithms. 
Drug
Equal Weighting Accuracy Weighing
Bayesian weightingAccuracy weighting Bayesian Weighting
Atv    0.00  0.00  0.00
Idv    0.00 20.40* 20.40*
Lpv    0.00   4.80*   4.80*
Nfv -2.60 11.70*   9.30*
Sqv    1.96*   5.90*   5.80*
Tpv    5.40*   9.70* 14.70*
3tc  0.10   7.40*  7.5*
Abc  0.00 10.20* 10.20*
Azt  1.00   6.60*   7.50*
d4t   0.00   7.40* 7.4*
Ddi -0.60   6.90*   6.30*
dlv   1.80 10.10* 11.80*
efv   0.00   8.50*   8.5*
nvp -0.50   3.80*   3.30*
tdf   0.10   2.70* 12.80*
* indicates a statistically significant difference.
 
 In order to determine if there is a statistical difference 
between the weighted voting method and the gold standard 
interpretation algorithms, the proportional Z-test was 
performed. Table 5 shows the Z scores of ANRS, REGA and 
HIVdb compared to Equal, Accuracy and Bayesian weighting 
algorithms.  In order to better understand the nature of the 
discrepancies of the Bayesian based weighting algorithm the 
percentages of the G1, G2 and G3 values were calculated as 
shown in Table 6.
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4. Discussion
  The key finding of this study was that is it possible to 
combine the gold standard interpretation algorithms in such 
a way as to improve their individual predictive ability. Table 
Two shows the accuracy of the ANRS, HIVdb, REGA, equal 
weighting, accuracy weighting, and Bayesian weighting 
algorithms. The equal, accuracy and Bayesian algorithms 
produce the same accuracy for atv. This is due to the fact 
that ANRS and HIVdb do not predict a resistance profile for 
atv. ANRS also does not predict a resistance profile for azt 
and dlv. Thus the weighting algorithms in this case will be 
based only on the output of HIV-db and REGA. 
  Overall the average accuracy of the equal weighting 
algorithm was 60.3% (SD = 10.0), the accuracy weighting 
algorithm 60% (SD=9.9) and the bayesian weighting 
algorithm  69% (SD=8.6). Applying Equations 4-6, resulted 
in Z-score of 9.9 (P<0.001) for equal and accuracy weighted 
voting and 18.3 (P<0.001) for the Bayesian based weighting 
algorithm. This indicates that the output of the algorithms 
were not obtained by chance. The Z-score for a comparison 
between the equal and accuracy weighting algorithms 
was calculated using Equations 4-6, and a score of 0.26 
(P=0.79) was obtained. This indicates that there is no overall 
statistical difference between equal and accuracy weighting 
algorithms. However, on comparing the equal and Bayesian 
weighting algorithms, a Z-score of 6.1 (P<0.01) was obtained. 
Similar results were obtained when comparing accuracy 
and Bayesian algorithms. This indicated that the Bayesian 
algorithm overall outperforms the accuracy and equal 
Table 5. 
Z scores of ANRS, REGA and HIVdb compared to equal, accuracy and Bayesian weighting algorithms.
Drug
Equal weighting Accuracy weighting Bayesian weighting
ANRS HIV-db REGA ANRS HIV-db REGA ANRS HIV-db REGA
Atv X X 0.0 X X   0.0 X X  0.0
Idv   1.7  2.1*   1.2  1.7   2.1*   1.2 25.3* 25.8* 24.8*
Lpv    8.4*  3.8* -1.6    8.4*   3.8* -1.6 13.6*   8.8*   3.3*
Nfv -2.0  0.5    2.3*   0.7   3.2*    5.0* 10.6* 13.3* 15.2*
Sqv   0.3 12.2*   3.0   0.4  12.4*    3.1*   6.4* 18.8*   9.2*
Tpv    2.6*   6.4*  11.7* -2.7   0.9    6.1* 13.1* 17.1* 22.8*
3tc   1.2   0.1 -0.1   1.1   0.0 -0.2   9.0*   7.8*   7.6*
Abc -3.0 -1.0 -3.7 -3.0 -1.0 -3.7   7.8*   9.9*   7.0*
Azt X -0.8 -1.1 X -1.8 -2.0 X   6.1*   5.8*
d4t    5.1* -2.0 -1.4    5.1* -2.0 -1.4 13.2*   5.7*   6.3*
Ddi -0.1    2.7*    3.0*   0.4     3.3*    3.6*   7.1* 10.1* 10.4*
Dlv X -1.2 -4.4 X -3.0 -6.1 X   9.4*   6.1*
Efv -3.7 -2.1 -3.7 -3.7 -2.1 -3.7   5.1*   6.7*   5.1*
Nvp    4.7*    3.5*    2.2*    5.1*    3.9*    2.6*   8.6*   7.4*   6.1*
Tdf -0.3    3.6*    2.1* -0.4    3.4*   1.9   2.5*   6.4*   4.8*
* indicates a statistically significant difference. X ANRS, HIVdb or REGA did not produce results for the associated drug.
Table 6. 
The percentage discrepancy between the resistance measures defined as G1, G2 and G3. 
Drug
ANRS HIVdb REGA Phenotype
G1 G2 G3 G1 G2 G3 G1 G2 G3 G2 G3
Atv X X X X X X 100.0   0.0   0.0 28.7   1.5
idv   38.9 60.1   0.0 51.0 49.0   0.0   96.9   3.1   0.0 30.4   0.3
lpv   84.0  8.6   0.0 86.9 13.1   0.0   91.1   8.9   0.0 22.5   1.8
nfv   44.8 39.9   0.0 37.1 62.8   0.1   37.9 62.1   0.0 35.1   0.4
sqv   59.8 26.0   0.2 53.7 46.3   0.0   50.4 49.6   0.0 32.1   1.2
tpv   87.0  7.4   0.3 71.4 28.6   0.1   75.5 24.5   0.0 24.1   0.8
3tc   92.7  3.7   0.0 98.4   1.6   0.0   97.9   2.1   0.0 13.3 17.4
abc   77.1 11.0   5.3 60.1 39.9   0.0   69.2 30.7   0.1 23.6 20.9
azt X  0.0 X 97.2   2.8   0.0   88.7 11.3   0.0 31.1 12.0
d4t   70.7  0.8 28.0 68.2 30.7   1.1   71.0 22.2   6.8 21.9 19.8
ddi   59.9 26.8   0.0 49.8 50.1   0.1   50.7 48.9   0.4 43.6   4.4
dlv X  0.0 X 90.3   9.7   0.1   98.9   1.0   0.1 13.0 19.4
efv 100.0  0.0   0.0 87.5 12.4   0.1   96.9   1.6   1.5 11.8 22.3
nvp   96.4  0.0   3.6 94.4   5.5   0.1   97.7   1.8   0.5   6.6 17.4
tdf   63.4  7.2 24.8 63.9 14.9 21.2   65.6 12.7 21.7 14.6   6.4
X= no results produced by the algorithm.
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weighting algorithms. Similar results where obtained for the 
PR and RT drugs separately.
  These results based on overall accuracy, is further proven 
using the Sailzberg[24] method. On comparing equal and 
accuracy weighting algorithms, Table Three shows that 
there is no statistical difference in 73% drugs. However, 
there are statically differences between 73% of all drugs 
when comparing equal and Bayesian weighting algorithms, 
and 67% of all drugs when comparing accuracy and 
Bayesian weighting algorithms. This indicates that there 
is a significant difference between the Bayesian weighting 
algorithm when compared to the accuracy as well as the 
equal based voting algorithms. From the average accuracies 
it may be deduced that the Bayesian based weighting 
algorithm performed the best in terms of predicting ARV 
resistance profiles as determined by IC50, while there is a 
slight difference between the equal and accuracy weighting 
algorithms[25,26]. 
  Similar results where obtained when the Z-scores are 
assessed for the comparison of the weighing algorithms using 
Salzberg’s method[23]. On comparing equal and accuracy 
weighting algorithms, there is no statistical difference 
in 86.7% drugs. However, there are statically differences 
between 93.3% of all drugs when comparing equal and 
Bayesian weighting algorithms, and accuracy and Bayesian 
weighting algorithms. 
  The weighting algorithms where compared to the REGA, 
HIV-db, and ANRS algorithms. The equal weighting 
algorithm showed difference in 33.7% of all the ARV drugs 
when compared to the ANRS algorithm. Fifty percent of the 
ARV drugs showed significant differences when HIV-db 
and Equal weighting algorithms were compared.  Similarly 
the REGA and equal weighting algorithms had a statistical 
difference in accuracy in 35.7% of the ARV’s.  This indicates 
that combining the gold standard interpretation algorithms 
does have a positive effect on predicting resistance 
measures.
  Similar to the equal algorithm there is an improvement 
in the prediction ability of the accuracy algorithm. The 
accuracy weighting algorithm showed difference in 25% of all 
the ARV drugs when compared to the ANRS algorithm. Fifty 
percent of the ARV drugs showed significant differences 
when HIV-db and accuracy weighting algorithms were 
compared.  Similarly the REGA and accuracy weighting 
algorithms had a statistical difference in accuracy in 35.7% 
of the ARV’s. 
  The Bayesian weighting algorithm showed difference in 
all the ARV drugs when compared to the ANRS algorithm. 
Similarly all of the ARV drugs showed significant differences 
when HIV-db and Bayesian weighting algorithms, and 
REGA and Bayesian weighting algorithms were compared. 
These results indicate that there are significant differences 
between the Bayesian weighting and HIV-db, ANRS, and 
REGA algorithms, and from the average accuracies it may 
be deduced that the Bayesian algorithm better predicts ARV 
resistance measures.
  The result shows the weighting of ANRS, HIV-db and 
REGA for each drug using the Bayesian weighing algorithm 
model. It is evident from the Figure 1 there is no clear single 
gold standard which determines the outcome of the Bayesian 
weighting algorithm.
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Figure 1. Weighting of each gold standard in the Bayesian based 
weighting algorithm.
  The higher percentage of Group 2 and lower percentage 
of Group 3 as shown in table Six, is also advantages in 
terms of the efficiency of the algorithm. This shows that the 
discrepancies are mostly one resistance measure away and 
that there is little major discordance. 
  From the results obtained it is evident that combining the 
gold standard interpretation algorithms may increase the 
predictive ability of the individual interpretation algorithms. 
This prototype study indicates that using  the Bayesian 
weighted voting method to improve the accuracy of the three 
individual goal standard interpretation algorithms is the 
most successful.
  This prototype study should be extended in order to create 
a more efficient and effective algorithm.  A dataset with a 
greater number of data elements should be used and other 
techniques to combine the gold standard interpretation 
algorithms should be considered. Possible options include 
machine learns algorithms, such as, support vector 
machines, multilayer perception neural networks and 
genetic programming. Thought should be given to designing 
this tool in such a manner that it may be integrated into an 
electronic medical record and a mobile interface design. 
This will serve as preliminary attempts to combine the fields 
of practicality defined medical informatics, bioinformatics 
and even telemedicine. 
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